INS and Hyperglycemia: Since higher cutoff can result in underestimation of β-cell function and may lead to unnecessary insulin treatment, while lower cutoff can overestimate β-cell function and impose the patients to the risk of hyperglycemia complications by unsuccessful transition to non-insulin therapy.